Hartford Great Health Corp. (HFUS)
USD 1.95
(0.0%)
USD 1.95
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.12 Million USD | 1064.79% |
| 2023 | -116.67 Thousand USD | 93.34% |
| 2022 | -55.84 Thousand USD | 36.52% |
| 2021 | -170.55 Thousand USD | -1500.52% |
| 2020 | -1.82 Million USD | 74.22% |
| 2019 | -668.79 Thousand USD | -2567.4% |
| 2018 | -25.07 Thousand USD | -34.21% |
| 2017 | -18.68 Thousand USD | 32.01% |
| 2016 | -27.47 Thousand USD | -32.89% |
| 2015 | -20.67 Thousand USD | 0.49% |
| 2014 | -5822.00 USD | -20.57% |
| 2013 | -17.23 Thousand USD | 20.21% |
| 2012 | -7475.00 USD | 27.94% |
| 2011 | -30.37 Thousand USD | -20.15% |
| 2010 | -24.93 Thousand USD | 31.41% |
| 2009 | -36.24 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 1.1 Million USD | 1758.24% |
| 2024 Q2 | -14.94 Thousand USD | 25.68% |
| 2024 Q3 | 30.34 Thousand USD | 496.53% |
| 2024 Q1 | -20.11 Thousand USD | -4.5% |
| 2023 Q2 | -21.36 Thousand USD | 60.97% |
| 2023 Q3 | -21.41 Thousand USD | -0.26% |
| 2023 Q4 | -26.22 Thousand USD | -22.44% |
| 2023 FY | - USD | 93.34% |
| 2023 Q1 | -54.73 Thousand USD | 19.17% |
| 2022 FY | - USD | 36.52% |
| 2022 Q2 | -588.81 Thousand USD | 8.67% |
| 2022 Q4 | -67.72 Thousand USD | 84.96% |
| 2022 Q1 | -644.73 Thousand USD | -28.39% |
| 2022 Q3 | -450.33 Thousand USD | 23.52% |
| 2021 Q2 | -1.05 Million USD | -65.43% |
| 2021 FY | - USD | -1500.52% |
| 2021 Q3 | -560.91 Thousand USD | 46.94% |
| 2021 Q4 | -502.17 Thousand USD | 10.47% |
| 2021 Q1 | -639.06 Thousand USD | -634.27% |
| 2020 Q1 | -384.43 Thousand USD | -11.07% |
| 2020 FY | - USD | 74.22% |
| 2020 Q2 | 532.12 Thousand USD | 238.42% |
| 2020 Q3 | -405.41 Thousand USD | -176.19% |
| 2020 Q4 | 119.61 Thousand USD | 129.5% |
| 2019 Q2 | -155.1 Thousand USD | -4037.18% |
| 2019 Q4 | -346.12 Thousand USD | -31.63% |
| 2019 FY | - USD | -2567.4% |
| 2019 Q3 | -262.94 Thousand USD | -69.53% |
| 2019 Q1 | -3749.00 USD | 45.25% |
| 2018 Q4 | -6847.00 USD | -33.39% |
| 2018 FY | - USD | -34.21% |
| 2018 Q3 | -5133.00 USD | 56.32% |
| 2018 Q2 | -11.75 Thousand USD | -775.71% |
| 2018 Q1 | -1342.00 USD | 69.96% |
| 2017 Q2 | -7042.00 USD | -282.51% |
| 2017 FY | - USD | 32.01% |
| 2017 Q4 | -4468.00 USD | 16.19% |
| 2017 Q3 | -5331.00 USD | 24.3% |
| 2017 Q1 | -1841.00 USD | 46.87% |
| 2016 Q1 | -7604.00 USD | -26.12% |
| 2016 FY | - USD | -32.89% |
| 2016 Q4 | -3465.00 USD | 40.82% |
| 2016 Q3 | -5855.00 USD | 44.52% |
| 2016 Q2 | -10.55 Thousand USD | -38.78% |
| 2015 Q1 | -1011.00 USD | 70.96% |
| 2015 Q4 | -6029.00 USD | -5.73% |
| 2015 Q3 | -5702.00 USD | 28.15% |
| 2015 Q2 | -7936.00 USD | -684.97% |
| 2015 FY | - USD | 0.49% |
| 2014 FY | - USD | -20.57% |
| 2014 Q3 | -6122.00 USD | 23.23% |
| 2014 Q2 | -7974.00 USD | -157.31% |
| 2014 Q1 | -3099.00 USD | -26.08% |
| 2014 Q4 | -3482.00 USD | 43.12% |
| 2013 Q4 | -2458.00 USD | 43.89% |
| 2013 FY | - USD | 20.21% |
| 2013 Q1 | -5859.00 USD | 13.01% |
| 2013 Q2 | -4536.00 USD | 22.58% |
| 2013 Q3 | -4381.00 USD | 3.42% |
| 2012 Q3 | -4009.00 USD | 1.01% |
| 2012 Q4 | -6735.00 USD | -68.0% |
| 2012 FY | - USD | 27.94% |
| 2012 Q1 | -6808.00 USD | -2872.93% |
| 2012 Q2 | -4050.00 USD | 40.51% |
| 2011 Q3 | -13.44 Thousand USD | -85.22% |
| 2011 FY | - USD | -20.15% |
| 2011 Q1 | -9044.00 USD | -96.69% |
| 2011 Q2 | -7259.00 USD | 19.74% |
| 2011 Q4 | -229.00 USD | 98.3% |
| 2010 Q2 | -11.61 Thousand USD | -209.4% |
| 2010 Q4 | -4598.00 USD | 7.78% |
| 2010 Q1 | -3755.00 USD | 0.0% |
| 2010 FY | - USD | 31.41% |
| 2010 Q3 | -4986.00 USD | 57.08% |
| 2009 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Portsmouth Square, Inc. | 4.06 Million USD | 72.309% |